Comparative study on the occurrence of adverse effects in the concomitant use of azathioprine and aldehyde oxidase inhibitors-Reference-Cited by-同舟云学术

Comparative study on the occurrence of adverse effects in the concomitant use of azathioprine and aldehyde oxidase inhibitors

Published:2023-12-14 Issue: Volume: Page:1-9
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Ueda Hinata¹,Narumi Katsuya¹²^ORCID,Asano Shuho¹,Saito Yoshitaka³,Furugen Ayako¹,Kobayashi Masaki¹²^ORCID

Affiliation:

1. Laboratory of Clinical Pharmaceutics & Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan

2. Education Research Center for Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan

3. Department of Clinical Pharmaceutics & Therapeutics, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, Sapporo, Japan

Funder

Japan Society for the Promotion of Science

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2023.2295976

Reference44 articles.

1. Azathioprine treatment and male fertility in inflammatory bowel disease

2. Safety of Thiopurine Therapy in Inflammatory Bowel Disease

3. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review

4. Low 6‐thioguanine nucleotide level: Effective in maintaining remission in Chinese patients with Crohn's disease

5. Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contribution of aldehyde oxidase to methotrexate-induced hepatotoxicity: in vitro and pharmacoepidemiological approaches;Expert Opinion on Drug Metabolism & Toxicology;2024-05-03